Alterations in early biochemical events following T cell activation in leprosy patients

N Sharma1, V K Sharma, A Gupta

  • 1Department of Dermatology, Venerology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.

Insights

Leprosy patients

Area of Science:

  • Immunology
  • Infectious Diseases
  • Cellular Biology

Background:

  • Leprosy presents diverse clinical forms, paucibacillary (TT/BT) and multibacillary (BL/LL), with distinct immune responses.
  • Understanding early lymphocyte activation and cytokine profiles is crucial for elucidating disease pathogenesis in leprosy.

Purpose of the Study:

  • To investigate early lymphocyte activation events and cytokine profiles (IL-2, IL-4, IL-6) in paucibacillary and multibacillary leprosy.
  • To assess the role of Mycobacterium leprae antigen (PGL-1) in modulating immune responses in different leprosy forms.

Main Methods:

  • Lymphocyte stimulation using phorbol myristate acetate/A23187 (PMA/A23187) and Mycobacterium leprae antigen (PGL-1).
  • Measurement of intracellular signaling molecules (IP3, calcium, protein kinase C) and cytokine levels (IL-2, IL-4, IL-6).
  • Comparative analysis between lymphocytes from TT/BT and BL/LL leprosy patients.

Main Results:

  • Lymphocytes from TT/BT patients exhibited greater proliferation to PMA/A23187 and PGL-1 compared to BL/LL.
  • Early activation markers (IP3, calcium, PKC) were elevated in both groups, with a significant increase in TT/BT post-PMA/A23187 stimulation.
  • PGL-1 marginally increased IP3 in TT/BT but had no effect in BL/LL. IL-2 was enhanced in TT/BT, while IL-4 and IL-6 were increased in BL/LL, further augmented by PGL-1.

Conclusions:

  • PGL-1 appears to be a key factor in driving the T-helper 2 (TH2) cytokine response characteristic of lepromatous leprosy (BL/LL).
  • Differential lymphocyte activation and cytokine profiles correlate with the clinical spectrum of leprosy, highlighting distinct immune responses.

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...